Implementation of clinical guidelines in Brazil: Should academic detailing be used?

Journal of Pharmaceutical Health Services Research

Volumn 7, Issue 2, 2016, Pages 105-115

  Costa, Juliana de Oliveira ^a   Almeida Brasil, Celline Cardoso ^a   Godman, Brian ^b,c   Fischer, Michael Adam ^d,e   Dartnell, Jonathan ^f   Heaney, Aine ^f   dos Santos, Carolina Greco Bernardes ^a   Acurcio, Francisco de Assis ^a   Álvares, Juliana ^a   Guerra, Augusto Afonso ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f NPS MedicineWise   (Australia)

Author keywords

Academic detailing; Brazil; Guideline adherence; Health policy

Indexed keywords

ACADEMIC DETAILING; ALZHEIMER DISEASE; ARTICLE; BRAZIL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HEALTH CARE QUALITY; HUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PUBLICATION; SYSTEMATIC REVIEW; WRITING;

EID: 84962495978     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/jphs.12133     Document Type: Article

References (41)

1. Brasil. Lei n° 8.080, de 19 de setembro de 1990: Dispõe sobre as condições para a promoção, proteção e recuperação da saúde, a organização eo funcionamento dos serviços correspondentes e dá outras providências. Diário Oficial da união 1990; 128: p. 18055.
2. Portaria no 221 de 01 de abril de 2002. Aprova a Diretrizes Clínicas e Protocolos Terapêuticos de Medicamentos Excepcionais e de Alto Custo no SUS. Transplantes Renais 2002.
3. Godman B et al. Initiatives among authorities to improve the quality and efficiency of prescribing and the implications. J Pharma Care Health Sys 2014; 1: 1-15.
4. Francke AL et al. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak 2008; 8: 38.
5. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003; 362: 1225-1230.
6. Holloway KA. Combating inappropriate use of medicines. Expert Rev Clin Pharmacol 2011; 4: 335-348.
7. Bjorkhem-Bergman L et al., Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur J Clin Pharmacol 2013; 69(Suppl. 1): 73-78.
8. Neuman J et al. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011; 343: d5621.
9. Sermet C et al. Ongoing pharmaceutical reforms in France: implications for key stakeholder groups. Appl Health Econ Health Policy 2010; 8: 7-24.
10. Godman B et al. Insight into recent reforms and initiatives in Austria: implications for key stakeholders. Expert Rev Pharmacoeconomics Outcomes Res 2008; 8: 357-371.
11. The Pew Charitable Trusts. Persuading the prescribers: pharmaceutical industry marketing and its influence on physicians and patients. http://www.pewtrusts.org/en/research-and-analysis/fact-sheets/2013/11/11/persuading-the-prescribers-pharmaceutical-industry-marketing-and-its-influence-on-physicians-and-patients, 2013.
12. Civaner M. Sale strategies of pharmaceutical companies in a "pharmerging" country: the problems will not improve if the gaps remain. Health Policy 2012; 106: 225-232.
13. Spurling GK et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med 2010; 7: e1000352.
14. Brkicic LS et al. Initiatives to improve prescribing efficiency for drugs to treat Parkinson's disease in Croatia: influence and future directions. Expert Rev Pharmacoeconomics Outcomes Res 2012; 12: 373-384.
15. Roehr B. Drug companies will have to report all payments to US doctors from March 2014. BMJ 2013; 346: f826.
16. Yu SY et al. New anti-rebate legislation in South Korea. Appl Health Econ Health Policy 2013; 11: 311-318.
17. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 1997; 157: 408-416.
18. Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA 1990; 263: 549-556.
19. O'Brien MA et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007; CD000409.
20. Grimshaw JM et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004; 8: iii-iv, 1-72.
21. Lomas J. Beyond the Sound of One Hand Clapping: A Discussion Document on Improving Health Research Dissemination and Uptake. Sydney: NSW Health Department, Research and Development Centre, 1997.
22. Bloom BS. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. Int J Technol Assess Health Care 2005; 21: 380-385.
23. Barton S. Using clinical evidence. BMJ 2001; 322: 503-504.
24. Godman B et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Rev Pharmacoeconomics Outcomes Res 2010; 10: 707-722.
25. Moon J et al. Different initiatives across Europe to enhance losartan utilisation post generics: impact and implications. Front Pharmacol 2014; 5(Article 219): 1-10.
26. Petersen R. Guia da Clínica Mayo Sobre mal de Alzheimer. Rio de Janeiro: Anima, 2006.
27. Brookmeyer R et al. Forecasting the global burden of Alzheimer's disease. Alzheimers Demen 2007; 3: 186-191.
28. Thomas RE, Lorenzetti DL. Interventions to increase influenza vaccination rates of those 60 years and older in the community. Cochrane Database Syst Rev 2014; 7: CD005188.
29. Barbui C et al. Implementation of treatment guidelines for specialist mental health care. Cochrane Database Syst Rev 2014; 1: CD009780.
30. Kahn SR et al. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism. Cochrane Database Syst Rev 2013; 7: CD008201.
31. Silva JM et al. Academic detailing and adherence to guidelines for Group B streptococci prenatal screening: a randomized controlled trial. BMC Pregnancy Childbirth 2013; 13: 68.
32. Gustafsson LL et al. The 'wise list' - a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol 2011; 108: 224-233.
33. Weekes LM et al. National Prescribing Service: creating an implementation arm for national medicines policy. Br J Clin Pharmacol 2005; 59: 112-116.
34. Dartnell J et al. NPS MedicineWise: a national approach to improving the quality of use of medicines. J Bras Econ Saúde 2015; 7(Suppl. 1): 3-5.
35. Jin M et al. A brief overview of academic detailing in Canada: another role for pharmacists. Can Pharm J (Ott) 2012; 145: 142-146.e2.
36. Maclure M et al. Show me the Evidence: Best Practices for Using Educational Visits to Promote Evidence-Based Prescribing. Victoria, BC: Canadian Academic Detailing Collaboration and Drug Policy Futures, 2006.
37. Almeida-Brasil CC et al. Compliance with clinical protocol and therapeutic guidelines on prescribing acetylcholinesterase inhibitors for treatment of Alzheimer's disease in Minas Gerais, Brazil. J Bras Econ Saude 2015; 7(Suppl. 1): 16.
38. Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care 2001; 39(8 Suppl 2):II46-II54.
39. Davis C, Abraham J. Is there a cure for corporate crime in the drug industry? BMJ 2013; 346: f755.
40. Abraham J. Pharmaceuticalization of society in context: theoretical empirical and health dimensions. Sociology 2010; 44: 603-622.
41. Cranney M et al. Why do GPs not implement evidence-based guidelines? A descriptive study Fam Pract 2001; 18: 359-363.